Scarica l'app Stockscreener
23.78
4.38%
-1.09
Dopo l'orario di chiusura:
23.70
-0.08
-0.34%
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Institution Moves: What is the Moat Score of Sutro Biopharma IncWeekly Risk Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Sutro Biopharma Hits New 52-Week High at $26.54, Up 548.83% - Markets Mojo
[EFFECT] SUTRO BIOPHARMA, INC. SEC Filing - Stock Titan
Market Outlook: Can Sutro Biopharma Inc continue delivering strong returns2026 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Sutro Biopharma enters sales agreement, may offer & sell shares of common stock of up to $100 millionSEC filing - MarketScreener
Sutro Biopharma Enters Sales Agreement, May Offer & Sell Shares Of Common Stock Of Up To $100 MillionSEC Filing - TradingView
Sutro Biopharma (NASDAQ: STRO) files $100M ATM shelf with TD Cowen - Stock Titan
Gains Report: Why is Sutro Biopharma Inc stock going down2026 Spike Watch & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Earnings Risk: Is now the right time to enter Sutro Biopharma IncWeekly Stock Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Value Recap: Is Sutro Biopharma Inc in a bullish channelMarket Sentiment Summary & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Sutro Biopharma (STRO) price target increased by 13.85% to 37.74 - msn.com
Hedge Fund Bets: What is the Moat Score of Sutro Biopharma Inc2026 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Sutro Biopharma (NASDAQ:STRO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Stock Market Recap: Is Sutro Biopharma Inc a potential multi baggerSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
HC Wainwright Lowers Earnings Estimates for Sutro Biopharma - marketbeat.com
Sutro Biopharma (NASDAQ:STRO) Upgraded by Truist Financial to "Strong-Buy" Rating - MarketBeat
Sutro Biopharma Inc buy Deutsche Bank Aktiengesellschaft - sharewise.com
Analyst James Shin Raises Price Target for Sutro Biopharma (STRO) to $55.00 | STRO Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Sutro Biopharma (NASDAQ:STRO) Stock Price - MarketBeat
Deutsche Bank Adjusts Sutro Biopharma Price Target to $55 From $51, Maintains Buy Rating - MarketScreener
HC Wainwright Predicts Sutro Biopharma FY2030 Earnings - MarketBeat
This Ralph Lauren Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Wells Fargo Upgrades Sutro Biopharma (STRO) with Significant Pri - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Raised to "Overweight" at Wells Fargo & Company - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Raised to Buy at HC Wainwright - MarketBeat
Wells Fargo Upgrades Sutro Biopharma to Overweight From Equal Weight, Adjusts PT to $27 From $8 - MarketScreener
H.C. Wainwright upgrades Sutro Biopharma stock rating to buy By Investing.com - Investing.com Canada
H.C. Wainwright upgrades Sutro Biopharma stock rating to buy - Investing.com
Sutro's FY25 Net Loss Narrows; On Track To Report Initial Phase 1 Data Of STRO-004 In Mid-2026 - RTTNews
Citizens reiterates Sutro Biopharma stock rating on pipeline progress By Investing.com - ca.investing.com
STRO Stock: HC Wainwright & Co. Upgrades Sutro Biopharma | STRO - GuruFocus
Sutro Biopharma (STRO) Receives Upgrade with Promising Outlook - GuruFocus
Citizens reiterates Sutro Biopharma stock rating on pipeline progress - Investing.com
Sutro Biopharma Reports 2025 Financial Results, Advances Dual-Payload ADC Pipeline, and Extends Cash Runway to 2028 - Minichart
Sutro Biopharma Annual Report 2023: Business Overview, Risk Factors, and Financial Analysis - Minichart
Sutro Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sutro Biopharma (NASDAQ: STRO) launches $100M ATM program with TD Cowen - Stock Titan
Sutro Biopharma Ends ATM Agreement After 2025 Results - TipRanks
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights - Bitget
Sutro Biopharma (NASDAQ:STRO) Issues Earnings Results - marketbeat.com
Sutro Biopharma 2025 10-K: $102.5M revenue, $(22.49) EPS - TradingView
Sutro Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Sutro Biopharma (NASDAQ: STRO) expands ADC pipeline and monetizes partnerships - Stock Titan
Revenue jumps as Sutro Biopharma (NASDAQ: STRO) narrows 2025 loss - Stock Titan
Q4 financial results released by Sutro Biopharma with operational update - Traders Union
BRIEF-Sutro Biopharma FY Revenue USD 102.484 Million Vs. IBES Estimate USD 99.2 Million - TradingView
Sutro Biopharma (STRO) 2024 Wells Fargo Healthcare Conference Summary - Quartr
If You Invested $1,000 in Sutro Biopharma (STRO) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Analyst Upgrade: Is now the right time to enter Sutro Biopharma Inc2026 Summary & Community Consensus Trade Alerts - baoquankhu1.vn
Bank Watch: Does H E Equipment Services Inc stock have upside surprise potentialCPI Data & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Aug Rallies: Why is Allegro MicroSystems Inc. stock going down2026 Update & Accurate Trade Setup Notifications - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 19.8% in February - MarketBeat
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 (NASDAQ:STRO) - Seeking Alpha
Sutro Biopharma, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 - Quiver Quantitative
Fed Meeting: What is the Moat Score of Sutro Biopharma Inc2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Sutro Biopharma (STRO) surges 11.9%: Is this an indication of further gains? - MSN
Sutro Biopharma Hits New 52-Week High of $25.68, Soars 556.88% - Markets Mojo
Sutro Biopharma Inc expected to post a loss of $4.34 a shareEarnings Preview - TradingView
Aug Swings: Can Sutro Biopharma Inc. continue delivering strong returns2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Sutro Biopharma Hits New 52-Week High of $21.40, Soars 453% - Markets Mojo
Sutro Biopharma (STRO) CEO reports RSU conversion and 282-share tax withholding - Stock Titan
Sutro Biopharma (STRO) GC exercises RSUs as shares withheld for taxes - Stock Titan
Sutro Biopharma Hits New 52-Week High at $20.47, Soars 430% - Markets Mojo
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):